isabelobrien, Author at European Medical Journal - Page 23 of 68

Sebastian Stintzing

Onc Now: Episode 13: Metastatic Colorectal Cancer Unravelled

Sebastian Stintzing, Head of Department of Medicine, Division of Hematology, Oncology, and Cancer Immunology, Charité – Universitäetsmedizin, Berlin, Germany, discusses the most impactful research into metastatic colorectal cancer.

DeepHealth’s Naiara Martínez Cabrera on AI's role in radiology

In this episode, uncover how AI is shaking up the radiology space with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth.

AstraZeneca buys EsoBiotec in $1bn cell therapy deal

AstraZeneca has announced a $1bn agreement to acquire EsoBiotec, a Belgian biotech firm pioneering in vivo cell therapies.

Woman's hand holding pill

Daily pill for endometriosis to be offered by NHS

The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.

Tackling bias, driving change: A roundtable for International Women’s Day

How can the pharmaceutical industry ‘Accelerate Action’ on gender parity this International Women’s Day? Find out now.

Xavier Leleu

Hema Now: Episode 12: Breaking Boundaries in Multiple Myeloma Research

Xavier Leleu, Head of the Department of Hematology at Centre Hospitalier Universitaire (CHU), Université de Poitiers, France

Cartoon brain on green background

Phase 2 trial begins for psychedelic-based depression treatment

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.

Hand with vaccine

UK Chikungunya vaccine approval in sight for Bavarian Nordic

The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.

Handshake on a green background

Jazz Pharmaceuticals to acquire Chimerix in $935m deal

In a deal worth approximately $935m, Jazz Pharmaceuticals is set to acquire Chimerix, a biotechnology company developing oncology therapies.

Heather McArthur

Onc Now: Episode 12: The Future of Breast Cancer Immunotherapy

Heather McArthur, Associate Professor in the Department of Medicine at University of Texas, UT Southwestern Medical Center, discusses recent advancements in breast cancer immunotherapy, and the future of personalised care.